Cargando…
Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs
Mood disorders (depression, bipolar disorders) are prevalent and disabling. They are also highly co-morbid with other psychiatric disorders. Currently there are no objective measures, such as blood tests, used in clinical practice, and available treatments do not work in everybody. The development o...
Autores principales: | Le-Niculescu, H., Roseberry, K., Gill, S. S., Levey, D. F., Phalen, P. L., Mullen, J., Williams, A., Bhairo, S., Voegtline, T., Davis, H., Shekhar, A., Kurian, S. M., Niculescu, A. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505261/ https://www.ncbi.nlm.nih.gov/pubmed/33828235 http://dx.doi.org/10.1038/s41380-021-01061-w |
Ejemplares similares
-
Towards precision medicine for anxiety disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs
por: Roseberry, K., et al.
Publicado: (2023) -
Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs
por: Niculescu, A. B., et al.
Publicado: (2019) -
Towards precision medicine for pain: diagnostic biomarkers and repurposed drugs
por: Niculescu, A. B., et al.
Publicado: (2019) -
Precision medicine for suicidality: from universality to subtypes and personalization
por: Niculescu, A B, et al.
Publicado: (2017) -
Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach
por: Niculescu, A B, et al.
Publicado: (2015)